Background*

Dr. Stephen J. Sullivan, Steve MD serves as a Managing Director at Skyline Ventures, Skyline Ventures IV, L.P. and Skyline Ventures III, L.P. Dr. Sullivan joined Skyline Ventures in 2000. Dr. Sullivan has been involved in managing and investing in healthcare companies and in practicing medicine since 1981. He co-founded HEALTHvision, Inc., in 1999. Since 1995, he was the First Clinician and served as one of the original employees at Eclipsys, where Dr. Sullivan served ... in sales, product management, and business development roles. He also served as a Chief Resident in Internal Medicine at Stanford in 1985. He serves as a Director at Alteer Corporation and iBalance Medical, Inc. He served as a Director at SpinalMotion Inc. He served as a Director at Novasys Medical, Inc. He served as the Board Observer of Satiety, Inc. He served as a Director of KAI Pharmaceuticals, Inc. and AcelRx Pharmaceuticals, Inc. He served as a Member of the Industrial Advisory Board of Cleveland Clinic Innovations. Dr. Sullivan serves on outside Advisory Boards at the University of San Francisco School of Business and the Pratt School of Engineering at Duke. He was a Member of the Industrial Advisory Board of New York University’s Catherine Reynolds Program in Social Entrepreneurship. Dr. Sullivan has held clinical faculty appointments at Brigham and Women's Hospital, Harvard Medical School, and Stanford University Medical School. He was an Internist for the National Hockey league's San Jose Sharks during their inaugural season from 1991 to 1992. For a decade, he had one of the largest medical practices in Silicon Valley, during which time Dr. Sullivan was intimately involved with the venture capital community. He completed a Program in Management Development at Harvard Business School in 1995. Dr. Sullivan received an M.D. from New York University Medical School and a B.S. Phi Beta Kappa from Duke University.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.